Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
RUNX1T1 / ETO is a member of the myeloid translocation gene family which interact with DNA-bound transcription factors and recruit a range of corepressors to facilitate transcriptional repression. The t(8;21)(q22;q22) translocation is one of the most frequent karyotypic abnormalities in acute myeloid leukemia. The translocation produces a chimeric gene made up of the 5'-region of the runt-related transcription factor 1 gene fused to the 3'-region of this gene. The chimeric protein is thought to associate with the nuclear corepressor/histone deacetylase complex to block hematopoietic differentiation. Alternative splicing results in multiple transcript variants.
|Gene Name:||runt-related transcription factor 1; translocated to, 1 (cyclin D-related)|
|Synonyms:||RUNX1T1, AML1T1, CBFA2T1, CDR, Eight twenty one protein, Cyclin-D-related protein, ETO, MTG8, Protein CBFA2T1, Protein ETO, ZMYND2, Protein MTG8|
|Target Sequences:||NM_004349 NP_004340.1 Q06455|
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.